Literature DB >> 31114991

LncRNA SNHG14 promotes the development of cervical cancer and predicts poor prognosis.

Y-Y Zhang1, M Li, Y-D Xu, J Shang.   

Abstract

OBJECTIVE: The aim of this study was to explore the role of long non-coding RNA (LncRNA) small nucleolar RNA host gene 14 (SNHG14) in cervical cancer, and to further understand the possible underlying mechanism. PATIENTS AND METHODS: Quantitative Real Time-Polymerase Chain Reaction (qRT-PCR) was performed to detect the expression of SNHG14 in cervical cancer. The relationship between SNHG14 expression with clinic-pathological features and prognosis of patients was analyzed. Cell Counting Kit-8 (CCK-8), 5-Ethynyl-2'-deoxyuridine (EdU) and flow cytometry were used to evaluate the proliferation and apoptosis of cells. At the same time, the changes in the expression of apoptosis-related proteins after SNHG14 knockdown were detected.
RESULTS: Compared with normal cervical tissues, the expression of SNHG14 was significantly higher in cervical cancer tissues. The prognosis of patients with higher expression of SNHG14 was worse than those with a lower level. The relationship between the expression of SNHG14 and clinicopathological features of patients with cervical cancer was further analyzed. The results demonstrated that a higher expression level of SNHG14 indicated later tumor stage and higher incidence of lymph node metastasis. Compared with normal cervical epithelial cell line End1/E6E7, the level of SNHG14 in cervical cancer cell lines (including SW756, SiHa and HeLa) was markedly up-regulated. Among them, SW756 and SiHa cells exhibited the highest level of SNHG14. After knocking down SNHG14, the viability and proliferation ability of SW756 and SiHa cells were remarkably decreased, while cell apoptosis was increased. Subsequently, we investigated the possible underlying mechanism. The results found that the knockdown of SNHG14 enhanced the activation of caspases-3, and increased the protein expression of Bax, JAK2 and STAT3, whereas decreased the expression of Bal-2 and Bid.
CONCLUSIONS: LncRNA SNHG14 was highly expressed in cervical tumor tissues or cells, which could promote the progression of cervical cancer. Furthermore, SNHG14 might be associated with the activation of the JAK-STAT pathway.

Entities:  

Year:  2019        PMID: 31114991     DOI: 10.26355/eurrev_201905_17790

Source DB:  PubMed          Journal:  Eur Rev Med Pharmacol Sci        ISSN: 1128-3602            Impact factor:   3.507


  11 in total

1.  Constructing a Novel Signature Based on Immune-Related lncRNA to Improve Prognosis Prediction of Cervical Squamous Cell Carcinoma Patients.

Authors:  Xuefeng Lv; Lu Liu; Pengxiang Li; Yingying Yuan; Mengle Peng; Huifang Jin; Dongchun Qin
Journal:  Reprod Sci       Date:  2022-01-24       Impact factor: 3.060

2.  LncRNA SNHG14 accelerates breast cancer progression through sponging miR-543 and regulating KLF7 expression.

Authors:  Daoping Zhang; Xu Ding; Meirong Peng
Journal:  Arch Gynecol Obstet       Date:  2021-11-16       Impact factor: 2.344

3.  Long non-coding RNA ARAP1-AS1 promotes the proliferation and migration in cervical cancer through epigenetic regulation of DUSP5.

Authors:  Han Min; Wenjing He
Journal:  Cancer Biol Ther       Date:  2020-09-28       Impact factor: 4.742

4.  Long Non-Coding RNA SNHG14 Contributes to the Development of Hepatocellular Carcinoma via Sponging miR-217.

Authors:  Xiaoyong Xu; Feihong Song; Xinwei Jiang; Han Hong; Qiang Fei; Zhengkang Jin; Xiang Zhu; Binghua Dai; Jiamei Yang; Chengjun Sui; Minhui Xu
Journal:  Onco Targets Ther       Date:  2020-05-29       Impact factor: 4.147

5.  Long Non-Coding RNA-NEAT1 Promotes Cell Migration and Invasion via Regulating miR-124/NF-κB Pathway in Cervical Cancer.

Authors:  Xiaofang Shen; Wei Zhao; Yumei Zhang; Bin Liang
Journal:  Onco Targets Ther       Date:  2020-04-17       Impact factor: 4.147

6.  Immune-Related Four-lncRNA Signature for Patients with Cervical Cancer.

Authors:  Jianfeng Zheng; Benben Cao; Xia Zhang; Zheng Niu; Jinyi Tong
Journal:  Biomed Res Int       Date:  2020-11-12       Impact factor: 3.411

7.  Long Non-Coding RNA (lncRNA) SNHG5 Participates in Vertical Sleeve Gastrectomy for Type II Diabetes Mellitus by Regulating TGR5.

Authors:  Weiwei Wei; Hao Tian; Xiandong Fu; Rongrong Yao; Dewang Su
Journal:  Med Sci Monit       Date:  2020-04-03

8.  Long noncoding RNA SNHG14 promotes the aggressiveness of retinoblastoma by sponging microRNA‑124 and thereby upregulating STAT3.

Authors:  Xiaowen Sun; Hui Shen; Shubin Liu; Jing Gao; Shuyan Zhang
Journal:  Int J Mol Med       Date:  2020-03-20       Impact factor: 4.101

9.  LncRNA SNHG14 contributes to the progression of NSCLC through miR-206/G6PD pathway.

Authors:  Lin Zhao; Xiaodong Zhang; Yantong Shi; Tianlu Teng
Journal:  Thorac Cancer       Date:  2020-03-09       Impact factor: 3.500

10.  Inhibition of HMGB1/RAGE axis suppressed the lipopolysaccharide (LPS)-induced vicious transformation of cervical epithelial cells.

Authors:  Lifang You; Hongyin Cui; Fen Zhao; Huier Sun; Huanxin Zhong; Guoli Zhou; Xuejun Chen
Journal:  Bioengineered       Date:  2021-12       Impact factor: 3.269

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.